DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Dubey D, Cano CA, Stüve O.
Update on monitoring and adverse effects of first generation disease modifying therapies and their recently approved versions in relapsing forms of multiple sclerosis.
Curr Opin Neurol 2016;
29: 272-277
We do not assume any responsibility for the contents of the web pages of other providers.